title: Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: Postoperative visual color changes after tranexamic acid administration.
authors.affiliation: Department of Anesthesiology, Mayo Clinic, 200 First Street, Southwest, Rochester, Minnesota 55905, USA.
authors.forename: Grant T
authors.initials: GT
authors.lastname: Cravens
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Brown
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Brown
authors.forename: C Thomas
authors.initials: CT
authors.lastname: Wass
mesh_terms: D000933:Antifibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002817:Chordoma / Q000601:surgery; D003118:Color Perception / Q000187:drug effects*; D003117:Color Vision Defects / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019635:Neurosurgical Procedures; D013125:Spinal Neoplasms / Q000601:surgery; D013131:Spine / Q000601:surgery*; D014148:Tranexamic Acid / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid